跳转到内容

Template:口服降糖药和胰岛素类似物：修订间差异

维基百科，自由的百科全书
以互动方式浏览历史
删除的内容 添加的内容
可视化wikitext
Wang65（留言 | 贡献）
3,154次编辑
←建立内容为“{{Navbox | name = 口服降糖药和胰岛素类似物 | title = 口服降糖药和胰岛素类似物 (A10) | listclass...”的新頁面
 
小 内容扩充 新条目
 
（未显示10个用户的19个中间版本）
第1行： 第1行：
{{Navbox
{{Navbox
| name = 口服降糖药和胰岛素类似物
| name = 口服降糖药和胰岛素类似物
| title = 口服[[降糖药]]和[[胰岛素]]类似物 ([[ATC代码 (A10)|A10]])
| title = 口服[[抗糖尿病药|降糖药]]和[[胰岛素]]类似物 ([[ATC代码 (A10)|A10]])
| listclass = hlist
| listclass = hlist
| groupstyle = background:#fd6;
| groupstyle = background:#fd6;
第9行： 第9行：
| groupstyle = background:#fd6;
| groupstyle = background:#fd6;


| group1 = [[抗糖尿病药物|增敏剂]]
| group1 = [[抗糖尿病药|增敏剂]]
| list1 = {{Navbox subgroup
| list1 = {{Navbox subgroup
| groupstyle = background:#fd6;
| groupstyle = background:#fd6;


| group1 = [[Biguanide]]s
| group1 = [[雙胍類]]
| list1 =
| list1 =
* [[Metformin]]<sup>#</sup>
* [[二甲双胍]]<sup>#</sup>
* [[Buformin]]<sup>‡</sup>
* [[丁双胍|丁福明]]<sup>‡</sup>
* [[Phenformin]]<sup>‡</sup>
* {{le|苯乙双胍|Phenformin}}<sup>‡</sup>


| group2 = [[Thiazolidinedione|TZD]]s ([[PPAR modulator|PPAR]])
| group2 = [[噻唑烷二酮類]] ([[活化受体调节剂]])
| list2 =
| list2 =
* {{le|環格列酮|Ciglitazone}}<sup>§</sup>
* [[Pioglitazone]]
* [[Rivoglitazone]]<sup>†</sup>
* [[达格列酮]]<sup>§</sup>
* {{le|恩格列酮|Englitazone}}<sup>§</sup>
* [[Rosiglitazone]]
* {{le|洛贝格列酮|Lobeglitazone}}
* [[Troglitazone]]<sup>‡</sup>
* {{le|萘格列酮|Netoglitazone}}<sup>§</sup>
* [[吡格列酮]]
* {{le|来格列酮|Rivoglitazone}}<sup>†</sup>
* [[罗格列酮]]
* {{le|曲格列酮|Troglitazone}}<sup>‡</sup>


| group3 = {{le|PPAR激动剂|PPAR agonist#Dual and pan PPAR agonists|双重活化受体激动剂}}
| group3 = [[PPAR_modulator#Dual-PPAR_modulators|Dual PPAR agonist]]
| list3 =
| list3 =
* [[Aleglitazar]]<sup>†</sup>
* {{le|阿格列扎|Aleglitazar}}<sup>†</sup>
* [[Muraglitazar]]<sup>§</sup>
* {{le|莫格他唑|Muraglitazar}}<sup>§</sup>
* {{le|沙羅格列扎|Saroglitazar}}
* [[Tesaglitazar]]<sup>§</sup>
* {{le|替格列扎|Tesaglitazar}}<sup>§</sup>
}}
}}


| group2 = [[抗糖尿病药物|促分泌素]]
| group2 = [[抗糖尿病药|促分泌素]]
| list2 = {{Navbox subgroup
| list2 = {{Navbox subgroup
| groupstyle = background:#fd6;
| groupstyle = background:#fd6;


| group1 = [[ATP-sensitive potassium channel|K+ ATP]]
| group1 = {{le|ATP敏感的钾通道|ATP-sensitive potassium channel|钾 ATP}}
| list1 = {{Navbox subgroup
| list1 = {{Navbox subgroup
| groupstyle = background:#fd6;
| groupstyle = background:#fd6;


| group1 = [[磺酰脲]]类
| group1 = [[磺酰脲类]]
| list1 =
| list1 =
* ''[[Sulfonylurea#First generation|1st generation]]'': [[Acetohexamide]]
* ''[[磺酰脲类#第一代|第一代]]'': {{le|醋酸己脲|Acetohexamide}}
* [[Carbutamide]]
* {{le|氨磺丁脲|Carbutamide}}
* [[Chlorpropamide]]
* {{le|氯磺丙脲|Chlorpropamide}}
* [[Glycyclamide|格列环脲]]
* [[Metahexamide]]
* {{le|美他己脲|Metahexamide}}
* [[Tolbutamide]]
* [[Tolazamide]]
* {{le|妥拉磺脲|Tolazamide}}
* {{le|甲苯磺丁脲|Tolbutamide}}


*''[[磺酰脲类#第二代|第二代]]'': [[格列苯脲]]
''[[Sulfonylurea#Second generation|2nd generation]]'': [[Glibenclamide|Glibenclamide (Glyburide)]]<sup>#</sup>
* [[Glibornuride]]
* {{le|格列波脲|Glibornuride}}
* {{le|格列卡胺|Glicaramide}}
* [[Glipizide]]
* {{le|格列吡嗪|Glipizide}}
* [[Gliquidone]]
* {{le|格列喹酮|Gliquidone}}
* [[Glisoxepide]]
* {{le|格列派特|Glisoxepide}}
* [[Glyclopyramide]]
* {{le|格列吡脲|Glyclopyramide}}
* [[Glimepiride]]
* [[Gliclazide]]
* [[格列美脲]]
* [[格列齐特]]<sup>#</sup>


| group2 = [[美各里替尼]]/"格列奈"
| group2 = {{le|美各里替尼|Meglitinide}}/"格列奈"
| list2 =
| list2 =
* [[Nateglinide]]
* {{le|那格列奈|Nateglinide}}
* [[Repaglinide]]
* [[瑞格列奈]]
* [[Mitiglinide]]
* {{le|米格列奈|Mitiglinide}}


}}
}}


| group3 = [[Glucagon-like peptide-1 analog|GLP-1 analogs]]
| group3 = [[胰高血糖素样肽-1受体激动剂|GLP-1类似物]]
| list3 =
| list3 =
* {{le|阿必鲁泰|Albiglutide}}<sup>‡</sup>
* [[Exenatide]]
* {{le|丹格列酮|Danuglipron}}
* [[Liraglutide]]
* {{le|杜拉魯肽|Dulaglutide}}
* [[Taspoglutide]]<sup>†</sup>
* [[艾塞那肽]]
* [[Albiglutide]]<sup>†</sup>
* [[Lixisenatide]]
* [[利拉鲁肽]]
* {{le|利西拉来|Lixisenatid}}
* {{le|洛替列酮|Lotiglipron}}
* {{le|奥氟列酮|Orforglipron}}<sup>§</sup>
* {{le|瑞他鲁肽|Retatrutide}}<sup>§</sup>
* [[司美格鲁肽]]
* {{le|他司鲁泰|Taspoglutide}}<sup>†</sup>
* [[替尔泊肽]]


| group4 = [[Dipeptidyl peptidase-4 inhibitor|DPP-4 inhibitor]]s
| group4 = [[二肽基肽酶-4抑制剂]]
| list4 =
| list4 =
* [[阿格列汀]]
* [[Alogliptin]]<sup>†</sup>
* {{le|安奈格列汀|Anagliptin}}
* [[Gemigliptin]]<sup>†</sup>
* {{le|依格列汀|Evogliptin}}
* [[Linagliptin]]
* [[Garvagliptin|加格列汀]]
* [[Saxagliptin]]
* {{le|吉米格列汀|Gemigliptin}}
* [[Sitagliptin]]
* {{le|戈塞列汀|Gosogliptin}}
* [[Vildagliptin]]
* [[利格列汀]]
* [[Melogliptin|美罗利汀]]
* [[奥格列汀]]
* [[沙格列汀]]
* [[西格列汀]]
* [[特力利汀]]
* {{le|曲格列汀|Trelagliptin}}
* [[维格列汀]]

| group5 = {{le|游离脂肪酸受体1|Free fatty acid receptor 1}}
| list5 =
* [[Fasiglifam|法西格利姆]]


}}
}}
第88行： 第115行：
| group3 = [[胰岛素类似物|类似物]]/其他胰岛素
| group3 = [[胰岛素类似物|类似物]]/其他胰岛素
| list3 =
| list3 =
* ''速效''
* ''fast-acting'' ([[Insulin lispro]]
* [[Insulin aspart]]
** {{le|赖脯胰岛素|Insulin lispro}}
* [[Insulin glulisine]])
** [[门冬胰岛素]]
** {{le|赖谷胰岛素|Insulin glulisine}}
* '' short-acting'' ([[Insulin therapy|Regular insulin]])
* ''短效''
* ''long-acting'' ([[Insulin glargine]]
** [[短效胰島素]]<sup>#</sup>
* [[Insulin detemir]]
* ''长效''
* [[NPH insulin]])
* ''ultra-long-acting'' ([[Insulin degludec]]<sup>†</sup>)
** [[甘精胰岛素]]<sup>#</sup>
** {{le|甘精胰岛素/利西拉来|Insulin glargine/lixisenatide|+利西拉来}}
* ''inhalable'' [[Inhalable insulin|Exubera]]<sup>‡</sup>
** [[地特胰岛素注射液|地特胰岛素]]<sup>#</sup>
** [[中效胰島素]]
** {{le|慢效胰島素|Lente insulin}}<sup>‡</sup>
** {{le|超慢效胰島素|Ultralente insulin}}<sup>‡</sup>
* ''超长效''
** {{le|德谷胰岛素|Insulin degludec}}<sup>#</sup>
** {{le|德谷胰岛素/门冬胰岛素|Insulin degludec/insulin aspart|+门冬胰岛素}}
** {{le|德谷胰岛素/利拉鲁肽|Insulin degludec/liraglutide|+利拉魯肽}}
** {{le|依柯胰岛素|Insulin icodec}}<sup>#</sup>
* ''可吸入''{{le|可吸入性胰岛素|Inhalable insulin|胰岛素}}<sup>‡</sup>
** Exubera<sup>‡</sup>
** Afrezza


}}
}}
第104行： 第143行：
| groupstyle = background:#fd6;
| groupstyle = background:#fd6;



| group3 = [[α-葡萄糖苷酶抑制药]]
| group1 = {{le|醛糖還原酶抑制藥|Aldose reductase inhibitor}}
| list1 =
* {{le|依帕司他|Epalrestat}}
* {{le|非达司他|Fidarestat}}<sup>§</sup>
* {{le|雷尼司他|Ranirestat}}<sup>†</sup>
* {{le|托瑞司他|Tolrestat}}<sup>‡</sup>
* {{le|澤那司他|Zenarestat}}<sup>§</sup>

| group3 = {{le|α-葡萄糖苷酶抑制药|Alpha-glucosidase inhibitor}}
| list3 =
| list3 =
* [[Acarbose]]
* {{le|阿卡波糖|Acarbose}}
* [[Miglitol]]
* {{le|米格列醇|Miglitol}}
* [[Voglibose]]
* {{le|伏格列波糖|Voglibose}}


| group8 = [[胰淀素]]类似物
| group8 = {{le|胰淀素|Amylin}}类似物
| list8 =
| list8 =
* [[Pramlintide]]
* {{le|普兰林肽|Pramlintide}}


| group11 = [[钠-葡萄糖协同转运蛋白2]][[钠-葡萄糖协同转运蛋白2抑制剂|抑制剂]]“格列净”
| group11 = [[Sodium-glucose transport proteins|SGLT2]] inhibitors
| list11 =
| list11 =
* [[Canagliflozin]]<sup>†</sup>
* {{le|坎格列净|Canagliflozin}}
* [[达格列净]]
* [[Dapagliflozin]]<sup>†</sup>
* [[Remogliflozin etabonate|Remogliflozin]]<sup>§</sup>
* [[恩格列淨]]<sup>#</sup>
* {{le|艾格列淨|Ertugliflozin}}
* [[Sergliflozin etabonate|Sergliflozin]]<sup>§</sup>
* {{le|伊格列净|Ipragliflozin}}
* {{le|鲁格列净|Luseogliflozin}}
* {{le|瑞莫格列淨依碳酸鹽|Remogliflozin etabonate|瑞莫格列淨}}<sup>§</sup>
* {{le|依碳酸舍格列净|Sergliflozin etabonate|舍格列净}}<sup>§</sup>
* {{le|托格列净|Tofogliflozin}}<sup>†</sup>


| group12 = 其他
| group12 = 其他
| list12 =
| list12 =
* [[Benfluorex]]<sup>‡</sup>
* [[苯氟雷司]]<sup>‡</sup>
* [[Tolrestat]]<sup>‡</sup>
* [[溴隱亭]]
* {{le|伊格列明|Imeglimin}}


}}
}}
第135行： 第189行：
}}<noinclude>
}}<noinclude>
[[Category:糖尿病药物]]
[[Category:糖尿病药物]]
[[Category:採用ATC碼的藥物模板]]
[[Category:採用ATC碼的藥物模板]]</noinclude>
[[en:Template:Oral hypoglycemics and insulin analogs]]</noinclude>

2024年11月29日 (五) 18:36的最新版本

检索自“https://zh.wikipedia.org/zhwiki/w/index.php?title=Template:口服降糖药和胰岛素类似物&oldid=85140100”